logo

Biotechnology & Drugs News

Share

Novartis Resolves Legacy Litigation Matters, Finalize Settlement Of Speaker Program Litigation

CENTOGENE Gets FDA Emergency Use Authorization For COVID-19 Molecular Diagnostic Test

Helsinn, MEI Pharma Discontinue Phase 3 Study With Pracinostat After Completing Interim Analysis